RNV Renerve Limited
Renerve (RNV) news
Renerve Limited is a public biotech or pharmaceutical company listed on ASX under the ticker RNV, recorded under Australia. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest Renerve news
We have not published a story on Renerve yet. When there is news, it will appear here.
Questions about Renerve
What is the ticker symbol of Renerve?
Renerve Limited trades under the ticker RNV on ASX.
Where is Renerve listed?
Renerve Limited is listed on ASX.
Which country or territory is Renerve listed under?
Our directory records Renerve Limited under Australia.
What does Renerve do?
Our directory classifies Renerve Limited as: Biotechnology. This is a directory classification, not a description of the pipeline.
What is the ISIN of Renerve?
The ISIN recorded for Renerve Limited is AU0000358616.
Does aibio.space cover Renerve?
aibio.space lists Renerve Limited among 2,820 public biotech companies and publishes its news here as stories appear.
Which companies are similar to Renerve?
Companies in our directory listed in the same country and business area as Renerve: Ceryvyn Therapeutics, Identifai Genetics, Immutep, Cambium Bio, Terragen Holdings, Holista Colltech.
Investor discussion: Renerve
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Stock chart
Listing details
- Company
- Renerve Limited
- Ticker
- RNV
- Listing
- ASX
- Country or territory
- Australia
- Business scope
- Biotechnology
- ISIN
- AU0000358616
- Last quote in directory
- 2026-10-22
- Directory source
- Listing page
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio